One study detected the expression of CD79b on patients with different types of B-cell malignancies including DLBCL, Burkitt lymphoma, FL, and evaluated the efficacy of anti-CD79b CAR-T cells in vitro and in vivo. The gene discussed is CD79B; the disease is Burkitt lymphoma.